Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Letter Commentary & Co-Mentions | Period / Date | Action |
|---|---|---|---|
“Biogen shares were pressured by the slow launch of the company's Alzheimer's drug, a novel treatment that requires extensive infrastructure buildup. Given our concerns...” | Q4 2024 Dec 31, 2024 | Preview | |
“Biogen trades for less than the value of their current drugs on the market. The market is...” | Q4 2024 Jan 13, 2025 | Preview |
Read unredacted commentary excerpts, portfolio weight disclosures, and high-conviction theses from hedge fund managers discussing $BIIB.(3 additional institutional mentions locked).
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
